R
Reshu Agarwal
Researcher at Acadia University
Publications - 64
Citations - 449
Reshu Agarwal is an academic researcher from Acadia University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 34 publications receiving 254 citations. Previous affiliations of Reshu Agarwal include Guru Gobind Singh Indraprastha University & Indian Space Research Organisation.
Papers
More filters
Journal ArticleDOI
Forest cover dynamics analysis and prediction modeling using logistic regression model
TL;DR: In this paper, the authors examined and analyzed the various explanatory variables associated with forest conversion process and predict forest cover change using logistic regression model (LRM) for the periods 1990 and 2000, derived from Landsat TM satellite imagery, was used to predict the forest cover for 2010.
Posted ContentDOI
Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial
Meenu Bajpai,S. Suresh Kumar,Ashish Maheshwari,Karan Chabra,Pratibha Kale,Amita Gupta,Ashad Narayanan,Ekta Gupta,Nirupama Ttrehanpati,Chhagan Bihari,Reshu Agarwal,Kamini Gupta,Upendra kumar Gupta,Ankit Bhardwaj,Guresh Kumar,Mojahidul Islam,Ravinder J. Singh,Pushpa Yadav,Rakhi Maiwall,Shiv Kumar Sarin +19 more
TL;DR: COPLA therapy resulted in rapid improvement in respiratory parameters and shortened time to clinical recovery, although no significant reduction in mortality was observed in this pilot trial.
Journal ArticleDOI
Pooled RNA sample reverse transcriptase real time PCR assay for SARS CoV-2 infection: A reliable, faster and economical method.
Ekta Gupta,Abhishek Padhi,Arvind Khodare,Reshu Agarwal,Krithiga Ramachandran,Vibha Mehta,Mousumi Kilikdar,Shantanu Dubey,Guresh Kumar,Shiv Kumar Sarin +9 more
TL;DR: It is demonstrated that pool testing with RNA samples can easily detect even up to a single positive sample with Ct value as high as 38, and that the results of pool testing is not affected by number of positive samples in a pool.
Journal ArticleDOI
A Recombinant Fragment of Human Surfactant Protein D Binds Spike Protein and Inhibits Infectivity and Replication of SARS-CoV-2 in Clinical Samples.
Taruna Madan,Barnali Biswas,Praveen M. Varghese,Praveen M. Varghese,Rambhadur Subedi,Hrishikesh Pandit,Susan Idicula-Thomas,Indra Kundu,Sheetalnath Rooge,Reshu Agarwal,Dinesh M. Tripathi,Savneet Kaur,Ekta Gupta,Sanjeev Gupta,Uday Kishore +14 more
TL;DR: In this paper, a human SP-D (surfactant protein D) is known to interact with SARS-CoV-2, which is an acute infectious disease caused by the severe acute respiratory syndrome coronavirus 2.
Journal ArticleDOI
Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial)
Meenu Bajpai,Ashish Maheshwari,Vikas Dogra,Suresh Kumar,Ekta Gupta,Pratibha Kale,Vandana Saluja,Sherin Sarah Thomas,Nirupama Trehanpati,Chhagan Bihari,Reshu Agarwal,Praveen Bharti,Prabha Shankar,Javid Hussain,Karan R. Chhabra,Amita Gupta,Ashad Narayanan,S. M. Agarwal,S Jain,Ankit Bhardwaj,Guresh Kumar,Birendra Kumar Yadav,Shiv Kumar Sarin +22 more
TL;DR: Convalescent plasma with adequate antibody titres should be transfused in COVID-19 patients along with SMT in the initial 3 days of hospitalisation for better clinical outcomes.